||Recombinant West Nile virus WNVgp1 (Accession # ABD85079) was produced in E. coli-derived.
||West Nile virus
|Predicted N Terminal:
||Met and Gly
||Lyophilized from a 0.2 µm filtered solution in Tris and NaCl.
||Measured by its ability to cleave the fluorogenic peptide substrate pERTKR-AMC .The specific activity is >750 pmol/min/µg, as measured under the described conditions.
||Recombinant West Nile virus WNVgp1 has a calculated MW of 27 kDa & 20 kDa. In SDS-PAGE migrates as 32 kDa and 22 kDa, reducing conditions.
||>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
||Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).